Literature DB >> 963909

Differences between plasma and serum complement in patients with chronic liver disease.

S Inai, H Kitamura, T Fujita, J Kojima, K Nagaki.   

Abstract

Of sixty patients with chronic liver disease, eight with cirrhosis or chronic hepatitis had very low serum CH50 but normal plasma CH50. The complement component profiles of these sera revealed markedly decreased C4 and C2 activities and normal C3T (C3-C9) activities. From these results, it is suggested that the early acting complement components had been non-specifically activated during blood coagulation in these patients. No difference between plasma and serum CH50 was found in patients with hepatitis B(s) antigen.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 963909      PMCID: PMC1541414     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  STUDIES ON THE FOURTH COMPONENT OF COMPLEMENT. I. TITRATION OF THE FOURTH COMPONENT OF COMPLEMENT IN HUMAN SERUM.

Authors:  S INAI; K FUJIKAWA; H TAKAHASHI; K NAGAKI
Journal:  Biken J       Date:  1964-01

2.  CHROMATOGRAPHIC SEPARATION OF THE FIRST COMPONENT OF COMPLEMENT AND ITS ASSAY ON A MOLECULAR BASIS.

Authors:  T BORSOS; H J RAPP
Journal:  J Immunol       Date:  1963-12       Impact factor: 5.422

3.  Ontogeny of the human complement system: in vitro biosynthesis of individual complement components by fetal tissues.

Authors:  H R Colten
Journal:  J Clin Invest       Date:  1972-04       Impact factor: 14.808

4.  Significance of serum complement levels in chronic liver disease.

Authors:  N D Finlayson; K Krohn; M H Fauconnet; K E Anderson
Journal:  Gastroenterology       Date:  1972-10       Impact factor: 22.682

5.  Synthesis of the ninth component of complement by a clonal strain of rat hepatoma cells.

Authors:  F A Rommel; M B Goldlust; F C Bancroft; M M Mayer; A H Tashjian
Journal:  J Immunol       Date:  1970-08       Impact factor: 5.422

6.  Ontogenesis of two components of human complement: beta1E and beta1C-1A globulins.

Authors:  M Adinolfi; B Gardner; C B Wood
Journal:  Nature       Date:  1968-07-13       Impact factor: 49.962

7.  Arthritis of hepatitis associated with Australia antigen.

Authors:  D K Onion; C S Crumpacker; B C Gilliland
Journal:  Ann Intern Med       Date:  1971-07       Impact factor: 25.391

8.  [Beta-1A-globulin in liver patients].

Authors:  U Kaboth; R Arnold
Journal:  Verh Dtsch Ges Inn Med       Date:  1969

9.  The inactivator of the first component of human complement (C1INA). The complex formation with the activated first component of human complement (C1) or with its subcomponents.

Authors:  K Nagaki; K Iida; S Inai
Journal:  Int Arch Allergy Appl Immunol       Date:  1974

10.  Relationship of hepatitis-associated antigen (H.A.A.) to acute and chronic liver injury.

Authors:  F J Dudley; R A Fox; S Sherlock
Journal:  Lancet       Date:  1971-07-03       Impact factor: 79.321

View more
  7 in total

1.  Cold-dependent activation of complement: recognition, assessment, and mechanism.

Authors:  K P Mathews; R A Mentyka; S L Chambers; T E Hugli; J H Herschbach; B L Zuraw
Journal:  J Clin Immunol       Date:  1992-09       Impact factor: 8.317

2.  The association of complement activation at a low temperature with hepatitis C virus infection in comparison with cryoglobulin.

Authors:  K Ueda; H Nakajima; T Nakagawa; A Shimizu
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

3.  Studies on circulating soluble immune complexes of the liver disease. 6. Comparative studies of 125I-pRF inhibition assay, 125I-Clq inhibition assay and 125I-Clq binding assay.

Authors:  J Narumoto
Journal:  Gastroenterol Jpn       Date:  1981

4.  A case of Menetrier's disease associated with protein-losing gastropathy and abnormal serum complement profile.

Authors:  M Kondo; H Nishibori; M Ikezaki; S Takemura; M Masuda
Journal:  Gastroenterol Jpn       Date:  1978

5.  The cold activation of the classical complement pathway: The cause of the differences between plasma and serum complement in liver cirrhosis.

Authors:  H Kitamura; K Nagaki; K Inoshita; K Iida; S Inai
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

Review 6.  The Role of Complement in Liver Injury, Regeneration, and Transplantation.

Authors:  Ebbe Billmann Thorgersen; Andreas Barratt-Due; Håkon Haugaa; Morten Harboe; Søren Erik Pischke; Per H Nilsson; Tom Eirik Mollnes
Journal:  Hepatology       Date:  2019-07-15       Impact factor: 17.425

7.  The Contribution of Serum Complement Component 3 Levels to 90-Day Mortality in Living Donor Liver Transplantation.

Authors:  Saeko Fukui; Masaaki Hidaka; Shoichi Fukui; Shimpei Morimoto; Takanobu Hara; Akihiko Soyama; Tomohiko Adachi; Hajime Matsushima; Takayuki Tanaka; Mai Fuchigami; Hiroo Hasegawa; Katsunori Yanagihara; Susumu Eguchi
Journal:  Front Immunol       Date:  2021-07-19       Impact factor: 8.786

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.